BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8313656)

  • 1. Analysis of natural killer (NK) cell subsets defined by the expression of two novel surface antigens (EB6 and GL183) in AIDS and AIDS-related conditions.
    Cauda R; Goletti D; Lucia MB; Tumbarello M; Rumi C; Orengo AM; Moretta A
    Clin Immunol Immunopathol; 1994 Mar; 70(3):198-205. PubMed ID: 8313656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
    Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E
    J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Ciccone E; Bulian P; Agostini C; Moretta A; Moretta L; Semenzato G
    Blood; 1993 May; 81(9):2381-5. PubMed ID: 8481518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.
    Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A
    Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities.
    Moretta A; Vitale M; Bottino C; Orengo AM; Morelli L; Augugliaro R; Barbaresi M; Ciccone E; Moretta L
    J Exp Med; 1993 Aug; 178(2):597-604. PubMed ID: 8340759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aging on distribution and functional activity of GL183+ and EB6+ NK cells.
    Mariani E; Gemma Monaco MC; Cattini L; De Zwart JF; Tripodi G; Orengo A; Facchini A
    Arch Gerontol Geriatr; 1992; 15 Suppl 1():249-56. PubMed ID: 18647694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune deficiency syndrome (AIDS).
    Plaeger-Marshall S; Spina CA; Giorgi JV; Mitsuyasu R; Wolfe P; Gottlieb M; Beall G
    J Clin Immunol; 1987 Jan; 7(1):16-23. PubMed ID: 3104390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.
    Moretta A; Sivori S; Vitale M; Pende D; Morelli L; Augugliaro R; Bottino C; Moretta L
    J Exp Med; 1995 Sep; 182(3):875-84. PubMed ID: 7650491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells.
    Vitale M; Sivori S; Pende D; Moretta L; Moretta A
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3536-40. PubMed ID: 7724594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous resolution of p58/EB6 antigen restricted NK-type lymphoproliferative disease of granular lymphocytes: role of Epstein Barr virus infection.
    Zambello R; Loughran TP; Trentin L; Rassu M; Facco M; Bortolin M; Nash R; Agostini C; Semenzato G
    Br J Haematol; 1997 Oct; 99(1):215-21. PubMed ID: 9359527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and lytic activity of NK cell subsets in the elderly.
    Mariani E; Monaco MC; Cattini L; Sinoppi M; Facchini A
    Mech Ageing Dev; 1994 Oct; 76(2-3):177-87. PubMed ID: 7885064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface molecules involved in CD3-negative NK cell function. A novel molecule which regulates the activation of a subset of human NK cells.
    Moretta A; Ciccone E; Tambussi G; Bottino C; Viale O; Pende D; Santoni A; Mingari MC
    Int J Cancer Suppl; 1989; 4():48-52. PubMed ID: 2478490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
    Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
    Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel surface molecules involved in human NK cell activation and triggering of the lytic machinery.
    Moretta A; Bottino C; Tripodi G; Vitale M; Pende D; Morelli L; Augugliaro R; Barbaresi M; Ciccone E; Millo R
    Int J Cancer Suppl; 1992; 7():6-10. PubMed ID: 1428407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity.
    Hu PF; Hultin LE; Hultin P; Hausner MA; Hirji K; Jewett A; Bonavida B; Detels R; Giorgi JV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):331-40. PubMed ID: 7552495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles.
    Moretta A; Vitale M; Sivori S; Bottino C; Morelli L; Augugliaro R; Barbaresi M; Pende D; Ciccone E; Lopez-Botet M; Moretta L
    J Exp Med; 1994 Aug; 180(2):545-55. PubMed ID: 8046333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in natural immunity during the course of HIV-1 infection.
    Brenner BG; Gryllis C; Gornitsky M; Wainberg MA
    Clin Exp Immunol; 1993 Aug; 93(2):142-8. PubMed ID: 7688673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Natural killer (NK) activity in patients with HIV infection].
    Ortona L; Tamburrini E; Tumbarello M; Ventura G; Cauda R
    Boll Ist Sieroter Milan; 1988; 67(2):135-41. PubMed ID: 3228497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD3+, CD56+ non-MHC restricted cytotoxic T lymphocytes in two fraternal AIDS patients: a case report.
    Warzynski MJ; Barbour SD; Winkler-Pickett RT; Ortaldo JR
    Cytometry; 1994 Dec; 18(4):231-6. PubMed ID: 7534677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.